Answers are grounded in this paper and cite their sources.
Background Head and neck tumors are frequently treated with radiotherapy, and mucositis is, in many cases, a limiting toxicity. Due to the low-level laser therapy contraindication in the tumoral area, the use of copaiba for the management of oral mucositis, given its anti-inflammatory and healing properties, was proposed. This study aimed to evaluate the dose-limiting toxicity/maximum tolerated dose of copaiba aqueous mouthwash solution. Methods This was a phase I trial with oral cavity or oropharynx cancer patients undergoing radiotherapy (NCT05308732; ID: 34635020.5.0000.5274). Using a modified Fibonacci design, up to six successive cohorts were proposed. The planned escalation dose levels were 10 mL of mouthwash with 10% in cohorts 1, 2, and 3, and 15% in cohorts 4, 5, and 6, two, three, and four times a day, respectively, associated with low-level laser therapy in non-tumoral areas. Daily assessments of oral mucositis and pain were performed. Results Twenty patients were included - 1 was excluded and 1 discontinued from cohort 1- and a total of 19 used the mouthwash. Most were women (57.9%), with a median age of 63.2 years, and performance status 1 (84.2%). Most tumors were squamous cell carcinomas (84.2%), 47.4% of them in the palate; 57.9% were staged as IVA. The median total radiotherapy dose was 68.0 Gy (60-70) delivered in 33 fractions (30-34.5). Pain in the oral cavity and oropharynx was referred in 73.7% and 52.6% of the cases, respectively. The highest grade of oral mucositis was 3; none of the patients developed grade 4 or had to have radiotherapy suspension due to this toxicity. None of the patients experienced dose-limiting toxicity related to the copaiba solution. Conclusion Copaiba mouthwash did not trigger dose-limiting toxicity in any of the patients throughout the cohorts. Therefore, the 15% solution, 4 times a day was established as the recommended phase II dose.
No takes yet. Share an insight, caveat, or question.
Menezes et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: